LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Neuropathology of α‐synuclein in Parkinson's disease

Photo from wikipedia

Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive movement disability accompanied by non‐motor symptoms. The neuropathology hallmark of PD is the loss of dopaminergic neurons predominantly in the… Click to show full abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive movement disability accompanied by non‐motor symptoms. The neuropathology hallmark of PD is the loss of dopaminergic neurons predominantly in the substantia nigra pars compacta and the presence of intracellular inclusions termed Lewy bodies (LBs), which are mainly composed of α‐synuclein (αSyn). Detailed staging based on the distribution and progression pattern of αSyn pathology in the postmortem brains of PD patients revealed correlation with the clinical phenotypes but not invariably. Cumulative evidence from cell and animal studies has implied that αSyn propagation contributes to the anatomical spread of αSyn pathology in the brain. Here, we recount the studies over the past two centuries on the anatomopathological foundations of PD documented. We also review studies on the structural analysis of αSyn and LBs, Braak staging of αSyn pathology, the cell‐to‐cell propagation of αSyn as well as αSyn fibril polymorphisms, which underlie the phenotypic differences in synucleinopathies.

Keywords: synuclein parkinson; parkinson disease; syn pathology; neuropathology synuclein; pathology

Journal Title: Neuropathology
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.